Biotech Cat (@biotechcat) 's Twitter Profile
Biotech Cat

@biotechcat

Biotech And More | Not Investment Advice | Will Make Mistakes, Always Learning | DMs Open

ID: 1516619753430867971

calendar_today20-04-2022 03:29:33

717 Tweet

2,2K Followers

336 Following

Biotech Cat (@biotechcat) 's Twitter Profile Photo

nice to see $GHRS win for BVF and RA I remember when co just launched People remember the early days of ATAI and Compass?

Seedy19tron (@seedy19tron) 's Twitter Profile Photo

. Meanwhile Saqib chilling 10b5-1 hitting no conferences to attend, no earnings calls to host , no approval launch conversations to be had. $swtx

HF Reflections (@hfreflection) 's Twitter Profile Photo

TRAITS OF A GOOD ANALYST (1/2) Over the past several years I’ve had 6 analysts who at some point reported me, and have interacted with countless more.  These are the traits I’ve found to be most correlated with long term success. They probably aren’t what you think. A 🧵 What I

Biotech Cat (@biotechcat) 's Twitter Profile Photo

Can anyone tell me what value $OVID has had for shareholders or the patient community for the past decade vs. Levin's committments (BIO chair, boards). To you is it a) neuro is really hard, b) mid execution, c) some other factor or d) I'm being too harsh

David Maris (@davidmaris) 's Twitter Profile Photo

Sometimes when an analyst or investor sees the COO of a public biotech company spending a couple of weeks hiking to Everest basecamp while its stock is $0.30, they think that maybe they should be working harder to fix the situation the company is in.

Biotech Cat (@biotechcat) 's Twitter Profile Photo

actually not going to play $ABVX catalyst...induction might hit (though am not personally convinced and don't love rr) but I am convinced maintenance misses can find better rr elsewhere for record was hoping drug works for pts but data may suggest otherwise